Docetaxel and vinorelbine: An effective regimen in recurrent squamous cell esophageal carcinoma

Medical Oncology

Volumn 20, Issue 1, 2003, Pages 19-24

  Airoldi, Mario ^a   Cortesina, Giorgio ^b   Giordano, Carlo ^b   Pedani, Fulvia ^a   Bumma, Cesare ^a   Gabriele, Pietro ^c  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

Chemotherapy; Docetaxel; Esophageal cancer; Squamous cell carcinoma; Vinorelbine

Indexed keywords

DOCETAXEL; NAVELBINE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DYSPHAGIA; ESOPHAGUS CANCER; FEMALE; HUMAN; MALE; METASTASIS; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; TAXOIDS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0037233673     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:20:1:19     Document Type: Article

References (20)

1. Enzinger PC, Ilson DH, Kelsen DP. Chemotherapy in esophageal cancer. Semin Oncol 1999; 26: 12-20.
2. Ajani JA, et al. Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 1994; 86: 1086-1091.
3. Einzig AI, et al. Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. Med Oncol 1996; 13: 87-93.
4. Kawamura H, et al. Antitumor activities of Taxotere and Taxol against human esophageal cancer. Proc Am Assoc Cancer Res 1997; 38: A1540 (abstract).
5. Vokes EE, Mauer AM, Hoffman PC, Haraf DJ. Combined modality therapy in non-small cell lung cancer and esophageal cancer: a phase I dose-escalation study of docetaxel with concurrent radiotherapy. Semin Oncol 1998; 25: 28-32.
6. Conroy T, et al. Phase II trial of vinorelbine in metastatic sqaumous cell esophageal carcinoma. J Clin Oncol 1996; 14: 164-170.
7. Bidoli P, et al. Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus. Tumori 2001; 87: 299-302.
8. Aoe K, et al. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines. Anticancer Res 1999; 19: 291-300.
9. Bissery MC, et al. Preclinical in vivo activity of docetaxel-containing combinations. Proc Am Soc Clin Oncol 1995; 14: 489 (abstract).
10. Hino M, et al. In vitro combination effect of docetaxel with vinca alkaloids on cancer cell line. Proc Am Assoc Cancer Res 1995; 36: 299 (abstract).
11. Fumoleau P, et al. Docetaxel combined with vinorelbine: a phase I results and new study designs. Oncology 1997; 6: 29-31.
12. Airoldi M, et al. Docetaxel + vinorelbine in recurrent heavily pre-treated head and neck cancer patients. Proc Am Soc Clin Oncol 1999; 18: 402 (abstract).
13. Cattel L, et al. A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions. Il Farmaco 2001; 56: 779-784.
14. Kelsen DP, Bains M, Cvitkovic E, Golbey R. Vindesine in the treatment of esophageal carcinoma: a phase II study. Cancer Treat Rep 1979; 63: 2019-2021.
15. Tubiana-Mathieu N, et al. Final results of phase II study of patients with metastatic or recurrent squamous cell carcinoma of the head and neck treated with docetaxel and 5-fluorouracil. Proc Am Soc Clin Oncol 2000; 19: 419 (abstract).
16. Oliveira J, et al. Activity of navelbine on lesions with previously irradiated fields in patients with metastatic and/or local recurrent squamous cell carcinoma of the head and neck: an EORTC-ECGS study. Proc Am Soc Clin Oncol 1997; 16: 406 (abstract).
17. Gaspar C, et al. A phase II study of vinorelbine, cisplatin and 5-fluorouracil in patients with locally advanced recurrent, and or metastatic squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 1999; 18: 406 (abstract).
18. Burris III HA. Single-agent docetaxel in randomized phase III trials. Semin Oncol 1999; 26: 1-6.
19. 2 vs vinorelbine/ifosfamide for non-small cell lung cancer previously treated with platinum-based chemotherapy. Proc Am Soc Clin Oncol 1999; 18: 460 (abstract).
20. Krug LM, et al. Phase II trial of dose dense docetaxel plus vinorelbine with prophylactic Filgrastim (G-CSF) in advanced non small cell lung cancer. Proc Am Soc Clin Oncol 1999; 18: 460 (abstract).